Oppenheimer on Q32 Bio Inc. (QTTB): ' We view the weakness as a misunderstanding'

October 1, 2026 6:03 AM

Oppenheimer analyst Jay Olson reiterated an Outperform rating and $40.00 price target on Q32 Bio Inc. (NASDAQ: QTTB).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found